Eden Biodesign expands Research Triangle Park Facility
Eden Biodesign Ltd. confirmed its expansion plans for Eden Biodesign, Inc., the Group's US subsidiary, with the announcement of a facility in the Research Triangle Park, North Carolina.
Eden Biodesign, Inc., will offer a range of cell line/strain development and early process development services. Eden Biodesign provides services in support of all major biopharmaceutical production technologies (mammalian, microbial and viral) and offers a "toolbox" of expression technologies, some via collaboration with partner companies.
"The selection of North Carolina's world-renowned Research Triangle Park signifies the strategic importance of the North American market to Eden Biodesign", said Dr. Crawford Brown, Chief Executive Officer, Eden Biodesign. "By establishing a subsidiary in the United States we are making it easier for clients to access Eden's proven expertise and inspected cGMP manufacturing facilities and confirming Eden's position as a recognized global player in the contract biopharmaceutical manufacturing services market".
Eden Biodesign is further cementing its commitment to the North American market with the recent appointment of Michael Faughnan as Business Development Director, who will be supporting the Company's expansion into the North American market from Southern California. The Company is actively developing technology and marketing collaborations with industry leaders throughout North America.
Most read news
Topics
Organizations
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Scientists identify genetic clues for a big heart
Artificial intelligence helps Stanford researchers predict drug combinations' side effects

CSIC study shows presence of monkeypox virus in air and saliva of infected patients - The work points to the possibility that the 'monkeypox virus' can also be transmitted by the airborne route

Analytica 2024: a guide to Laboratory 4.0 - Greater efficiency through laboratory robots and artificial intelligence
Our_Bodies,_Ourselves
Novartis completes shipment of US supply of Fluvirin seasonal influenza vaccine
